Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shiho Sakai

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
BMC Psychiatry|May 30, 2016
Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: a 6-month, open-label, randomized, pilot trialYoshiteru Takekita, Yosuke Koshikawa, Chiara Fabbri, et al.
Journal of Psychiatric Research|February 19, 2017
Non response at week 4 as clinically useful indicator for antidepressant combination in major depressive disorder. A sequential RCTMasaki Kato, Yoshiteru Takekita, Yosuke Koshikawa, et al.
Journal of Clinical Psychopharmacology|March 31, 2015
HTR1A Gene Polymorphisms and 5-HT1A Receptor Partial Agonist Antipsychotics Efficacy in SchizophreniaYoshiteru Takekita, Chiara Fabbri, Masaki Kato, et al.
European Archives of Psychiatry and Clinical Neuroscience|May 29, 2015
Antagonist and partial agonist at the dopamine D2 receptors in drug-naïve and non-drug-naïve schizophrenia: a randomized, controlled trialYoshiteru Takekita, Chiara Fabbri, Masaki Kato, et al.
Neuropsychobiology|January 27, 2016
The Comparative Effects of Risperidone Long-Acting Injection and Paliperidone Palmitate on Social Functioning in Schizophrenia: A 6-Month, Open-Label, Randomized Controlled Pilot TrialYosuke Koshikawa, Yoshiteru Takekita, Masaki Kato, et al.
Genes|September 10, 2020
Plant-Specific Domains and Fragmented Sequences Imply Non-Canonical Functions in Plant Aminoacyl-tRNA SynthetasesYusuke Saga, Moeka Kawashima, Shiho Sakai, et al.
Clinical Nutrition (Edinburgh, Scotland)|October 3, 2024
Malnutrition defined by global leadership initiative on malnutrition criteria impedes home discharge in acute care hospital admissionsTakeshi Saijo, Daisuke Mori, Tomomi Okamoto, et al.
Journal of Affective Disorders|June 22, 2017
The relationship between circulating mitochondrial DNA and inflammatory cytokines in patients with major depressionYuki Kageyama, Takaoki Kasahara, Masaki Kato, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|February 23, 2022
Pre-treatment plasma cytokine levels as potential predictors of short-term remission of depressionKiyokazu Atake, Hikaru Hori, Yuki Kageyama, et al.
Stem Cells (Dayton, Ohio)|March 19, 2022
Erk5 in Bone Marrow Mesenchymal Stem Cells Regulates Bone Homeostasis by Preventing Osteogenesis in AdulthoodTetsuhiro Horie, Kazuya Fukasawa, Takanori Yamada, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
BMC Psychiatry|May 30, 2016
Cognitive function and risperidone long-acting injection vs. paliperidone palmitate in schizophrenia: a 6-month, open-label, randomized, pilot trialYoshiteru Takekita, Yosuke Koshikawa, Chiara Fabbri, et al.
Journal of Psychiatric Research|February 19, 2017
Non response at week 4 as clinically useful indicator for antidepressant combination in major depressive disorder. A sequential RCTMasaki Kato, Yoshiteru Takekita, Yosuke Koshikawa, et al.
Journal of Clinical Psychopharmacology|March 31, 2015
HTR1A Gene Polymorphisms and 5-HT1A Receptor Partial Agonist Antipsychotics Efficacy in SchizophreniaYoshiteru Takekita, Chiara Fabbri, Masaki Kato, et al.
European Archives of Psychiatry and Clinical Neuroscience|May 29, 2015
Antagonist and partial agonist at the dopamine D2 receptors in drug-naïve and non-drug-naïve schizophrenia: a randomized, controlled trialYoshiteru Takekita, Chiara Fabbri, Masaki Kato, et al.
Neuropsychobiology|January 27, 2016
The Comparative Effects of Risperidone Long-Acting Injection and Paliperidone Palmitate on Social Functioning in Schizophrenia: A 6-Month, Open-Label, Randomized Controlled Pilot TrialYosuke Koshikawa, Yoshiteru Takekita, Masaki Kato, et al.
Genes|September 10, 2020
Plant-Specific Domains and Fragmented Sequences Imply Non-Canonical Functions in Plant Aminoacyl-tRNA SynthetasesYusuke Saga, Moeka Kawashima, Shiho Sakai, et al.
Clinical Nutrition (Edinburgh, Scotland)|October 3, 2024
Malnutrition defined by global leadership initiative on malnutrition criteria impedes home discharge in acute care hospital admissionsTakeshi Saijo, Daisuke Mori, Tomomi Okamoto, et al.
Journal of Affective Disorders|June 22, 2017
The relationship between circulating mitochondrial DNA and inflammatory cytokines in patients with major depressionYuki Kageyama, Takaoki Kasahara, Masaki Kato, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|February 23, 2022
Pre-treatment plasma cytokine levels as potential predictors of short-term remission of depressionKiyokazu Atake, Hikaru Hori, Yuki Kageyama, et al.
Stem Cells (Dayton, Ohio)|March 19, 2022
Erk5 in Bone Marrow Mesenchymal Stem Cells Regulates Bone Homeostasis by Preventing Osteogenesis in AdulthoodTetsuhiro Horie, Kazuya Fukasawa, Takanori Yamada, et al.
Pageof 2